These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12124980)

  • 1. Antisense MBD2 gene therapy inhibits tumorigenesis.
    Slack A; Bovenzi V; Bigey P; Ivanov MA; Ramchandani S; Bhattacharya S; tenOever B; Lamrihi B; Scherman D; Szyf M
    J Gene Med; 2002; 4(4):381-9. PubMed ID: 12124980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo.
    Campbell PM; Bovenzi V; Szyf M
    Carcinogenesis; 2004 Apr; 25(4):499-507. PubMed ID: 14688029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor activity of a combination of MBD2-antisense electrotransfer gene therapy and bleomycin electrochemotherapy.
    Ivanov MA; Lamrihi B; Szyf M; Scherman D; Bigey P
    J Gene Med; 2003 Oct; 5(10):893-899. PubMed ID: 14533198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
    Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
    Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP; Lyker JS; Huang L; Siegfried JM
    Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
    Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma.
    Zhu Y; Spitz MR; Zhang H; Grossman HB; Frazier ML; Wu X
    Cancer; 2004 May; 100(9):1853-8. PubMed ID: 15112265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.
    Sabbioni S; Callegari E; Spizzo R; Veronese A; Altavilla G; Corallini A; Negrini M
    Cancer Gene Ther; 2007 Mar; 14(3):297-305. PubMed ID: 17218949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate.
    Kunisaki R; Ikawa S; Maeda T; Nakazaki Y; Kurita R; Harata M; Shutoh Y; Bai YS; Soda Y; Tanabe T; Dohi T; Kato R; Ikawa Y; Asano S; Tani K
    J Gene Med; 2006 Sep; 8(9):1121-30. PubMed ID: 16832836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated anti insulin-like growth factor I gene transfer for the treatment of hepatocellular carcinoma.
    Lafarge-Frayssinet C; Martin C; Van Binh PN; Achard-Ellouk S; Duc HT; Frayssinet C; Cardoso G; Desauty G; Warnet JM; Bréchot C; Sarasin A
    Anticancer Res; 2002; 22(6C):3895-904. PubMed ID: 12553010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
    Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of retroviral vector containing anti-sense Smad4 gene on Ito cell line, LI90.
    Xu XB; Leng XS; He ZP; Liang ZQ; Lin K; Wei YH; Yu X; Peng JR
    Chin Med J (Engl); 2004 Aug; 117(8):1170-7. PubMed ID: 15361290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis.
    Hahn W; Ho SH; Jeong JG; Hahn EY; Kim S; Yu SS; Kim S; Kim JM
    Gene Ther; 2004 May; 11(9):739-45. PubMed ID: 15103317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense integrin alphaV and beta3 gene therapy suppresses subcutaneously implanted hepatocellular carcinomas.
    Li J; Tan H; Dong X; Xu Z; Shi C; Han X; Jiang H; Krissansen GW; Sun X
    Dig Liver Dis; 2007 Jun; 39(6):557-65. PubMed ID: 17374519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.
    Pakneshan P; Szyf M; Rabbani SA
    Carcinogenesis; 2005 Mar; 26(3):557-64. PubMed ID: 15618232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
    Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
    Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.